|
|
|
|
|
|
|
M Tue W Th F |
|
11 August, 2026 |
|
|
|
|
|
|
|
|
|
|
We're still wrapping our heads around the feasibility of what President Donald Trump asked for in his executive order on the childhood vaccine schedule yesterday. Vaccine manufacturers behind the MMR shots aren't supportive, and it's likely to immediately face legal challenges. All while the president concluded that the shot causes autism, contrary to years of clinical research. |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
 |
|
|
When Exelixis CEO Michael Morrissey rolled out the biotech's final numbers for 2025 earlier in the year, there was no mistaking the outsized role that... |
|
|
|
|
|
by Nicole DeFeudis
|
The pharma industry is bringing its 340B fight to Illinois. AbbVie, Novartis and Bristol Myers Squibb each filed separate lawsuits over the last week against... | |
|
|
|
|
|
|
by Max Bayer
|
President Donald Trump further asserted control over the nation’s childhood vaccine schedule, calling for the measles, mumps and rubella (MMR) vaccine to split into three... | |
|
|
|
|
|
|
|
 |
|
|
|
by ENDPOINTS |
Plus news about Tenax Therapeutics, Aureka Biotechnologies, ATyr Pharma, Prana Therapies and Mereo BioPharma. 💸 Lilly’s vaccine acquisitions:In May, Eli Lilly said it would... | |
|
|
|
|
|
|
|
Worldwide made. Thanks for reading.
|
|
|
|
|
|
|
|
